Induction of apoptosis by curcumin: Mediation by glutathione S-transferase P1-1 inhibition

Biochemical Pharmacology

Volumn 66, Issue 8, 2003, Pages 1475-1483

  Duvoix, Annelyse ^a   Morceau, Franck ^a   Delhalle, Sylvie ^a   Schmitz, Martine ^a   Schnekenburger, Michaël ^a   Galteau, Marie Madeleine ^b   Dicato, Mario ^a   Diederich, Marc ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

12 O tetradecanoylphorbol 13 acetate; Activating protein 1; AP 1; Apoptosis; Carcinogenesis; Curcumin; Drug resistance; Glutathione S transferase; GST; GSTP1 1; Leukemia; NF B; Nuclear factor B; TNF ; TPA; Tumour necrosis factor

Indexed keywords

CASPASE 8; CASPASE 9; CURCUMIN; GLUTATHIONE TRANSFERASE P1 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHORBOL ESTER; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ENZYME INHIBITOR; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN; PHORBOL 13 ACETATE 12 MYRISTATE;

APOPTOSIS; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; GENE ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; ARTICLE; BIOSYNTHESIS; CELL STRAIN K 562; CELL SURVIVAL; DRUG ANTAGONISM; DRUG INTERACTION; METABOLISM;

APOPTOSIS; CELL SURVIVAL; CURCUMIN; DRUG INTERACTIONS; ENZYME INHIBITORS; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; K562 CELLS; NF-KAPPA B; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0242568173     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00501-X     Document Type: Conference Paper

References (50)

1. Castro V.M., Soderstrom M., Carlberg I., Widersten M., Platz A., Mannervik B. Differences among human tumor cell lines in the expression of glutathione transferases and other glutathione-linked enzymes. Carcinogenesis. 11(9):1990;1569-1576.
2. Xia C., Hu J., Ketterer B., Taylor J.B. The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem. J. 313(Pt 1):1996;155-161.
3. Morrow C.S., Goldsmith M.E., Cowan K.H. Regulation of human glutathione S-transferase pi gene transcription: influence of 5′-flanking sequences and trans-activating factors which recognize AP-1-binding sites. Gene. 88(2):1990;215-225.
4. Schipper L. Glutathione S-transferases and cancer. Int. J. Oncol. 10:1997;1261-1264.
5. Morrow C.S., Smitherman P.K., Townsend A.J. Combined expression of multidrug resistance protein (MRP) and glutathione S-transferase P1-1 (GSTP1-1) in MCF7 cells and high level resistance to the cytotoxicities of ethacrynic acid but not oxazaphosphorines or cisplatin. Biochem. Pharmacol. 56(8):1998;1013-1021.
6. Moscow J.A., Townsend A.J., Cowan K.H. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins. Mol. Pharmacol. 36(1):1989;22-28.
7. Masanek U., Stammler G., Volm M. Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin taxol and cisplatin. Anticancer Drugs. 8(2):1997;189-198.
8. Puchalski R.B., Fahl W.E. Expression of recombinant glutathione S-transferase pi, Ya, or Yb1 confers resistance to alkylating agents. Proc. Natl. Acad. Sci. U.S.A. 87(7):1990;2443-2447.
9. Miyazaki M., Kohno K., Saburi Y., Matsuo K., Ono M., Kuwano M., Tsuchida S., Sato K., Sakai M., Muramatsu M. Drug resistance to cis- diamminedichloroplatinum(II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene. Biochem. Biophys. Res. Commun. 166(3):1990;1358-1364.
10. Cookson M.S., Reuter V.E., Linkov I., Fair W.R. Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J. Urol. 157(2):1997;673-676.
11. Inoue T., Ishida T., Sugio K., Maehara Y., Sugimachi K. Glutathione S-transferase pi is a powerful indicator in chemotherapy of human lung squamous-cell carcinoma. Respiration. 62(4):1995;223-227.
12. Sauerbrey A., Zintl F., Volm M. P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia. Br. J. Cancer. 70(6):1994;1144-1149.
13. Schisselbauer J.C., Silber R., Papadopoulos E., Abrams K., LaCreta F.P., Tew K.D. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res. 50(12):1990;3562-3568.
14. Toffoli G., Frustaci S., Tumiotto L., Talamini R., Gherlinzoni F., Picci P., Boiocchi M. Expression of MDR1 and GST-pi in human soft tissue sarcomas: relation to drug resistance and biological aggressiveness. Ann. Oncol. 3(1):1992;63-69.
15. Monden N., Abe S., Sutoh I., Hishikawa Y., Kinugasa S., Nagasue N. Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer. Oncology. 54(5):1997;391-399.
16. Bierhaus A., Zhang Y., Quehenberger P., Luther T., Haase M., Muller M., Mackman N., Ziegler R., Nawroth P.P. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb. Haemost. 77(4):1997;772-782.
17. Chen Y.R., Tan T.H. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene. 17(2):1998;173-178.
18. Singh S., Aggarwal B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J. Biol. Chem. 270(42):1995;24995-25000.
19. Chan M.M. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol. 49(11):1995;1551-1556.
20. Rao C.V., Rivenson A., Simi B., Reddy B.S. Chemoprevention of colon carcinogenesis by dietary curcumin a naturally occurring plant phenolic compound. Cancer Res. 55(2):1995;259-266.
21. Satoskar R.R., Shah S.J., Shenoy S.G. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int. J. Clin. Pharmacol. Ther. Toxicol. 24(12):1986;651-654.
22. Tanaka T., Makita H., Ohnishi M., Hirose Y., Wang A., Mori H., Satoh K., Hara A., Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene. Cancer Res. 54(17):1994;4653-4659.
23. Huang M.T., Lou Y.R., Ma W., Newmark H.L., Reuhl K.R., Conney A.H. Inhibitory effects of dietary curcumin on forestomach duodenal and colon carcinogenesis in mice. Cancer Res. 54(22):1994;5841-5847.
24. Huang M.T., Smart R.C., Wong C.Q., Conney A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48(21):1988;5941-5946.
25. Ammon H.P., Wahl M.A. Pharmacology of Curcuma longa. Planta Med. 57(1):1991;1-7.
26. Shankar T.N., Shantha N.V., Ramesh H.P., Murthy I.A., Murthy V.S. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, uineapigs & monkeys. Indian J. Exp. Biol. 18(1):1980;73-75.
27. Huang M.T., Lysz T., Ferraro T., Abidi T.F., Laskin J.D., Conney A.H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51(3):1991;813-819.
28. Flynn D.L., Rafferty M.F., Boctor A.M. Inhibition of 5-hydroxy- eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot. Med. 22(3):1986;357-360.
29. Huang M.T., Wang Z.Y., Georgiadis C.A., Laskin J.D., Conney A.H. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis. 13(11):1992;2183-2186.
30. Azuine M.A., Bhide S.V. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer. 17(1):1992;77-83.
31. Azuine M.A., Bhide S.V. Protective single/combined treatment with betel leaf and turmeric against methyl (acetoxymethyl) nitrosamine-induced hamster oral carcinogenesis. Int. J. Cancer. 51(3):1992;412-415.
32. Müller M.M., Schreiber E., Schaffner W., Matthias P. Rapid test for in vivo stability and DNA binding of mutated octamer binding proteins with 'mini-extracts' prepared from transfected cells. Nucleic Acids Res. 17(15):1989;6420.
33. Borde-Chiche P., Diederich M., Morceau F., Wellman M., Dicato M. Phorbol ester responsiveness of the glutathione S-transferase P1 gene promoter involves an inducible c-jun binding in human K562 leukemia cells. Leuk. Res. 25(3):2001;241-247.
34. Singh S., Aggarwal B.B., Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B J. Biol. Chem. 270(18):1995;10631-10639.
35. Han S.S., Keum Y.S., Seo H.J., Surh Y.J. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J. Biochem. Mol. Biol. 35(3):2002;337-342.
36. Lamph W.W., Wamsley P., Sassone-Corsi P., Verma I.M. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature. 334(6183):1988;629-631.
37. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 49(6):1987;741-752.
38. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30(6):1995;445-600.
39. Moffat G.J., McLaren A.W., Wolf C.R. Involvement of Jun and Fos proteins in regulating transcriptional activation of the human pi class glutathione S-transferase gene in multidrug-resistant MCF7 breast cancer cells. J. Biol. Chem. 269(23):1994;16397-16402.
40. Reed J.C. Mechanisms of apoptosis. Am. J. Pathol. 157(5):2000;1415-1430.
41. Mukhopadhyay A., Bueso-Ramos C., Chatterjee D., Pantazis P., Aggarwal B.B. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 20(52):2001;7597-7609.
42. Bush J.A., Cheung K.J. Jr., Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp. Cell Res. 271(2):2001;305-314.
43. Barthi A.C., Donato N., Singh S., Aggarwal B.B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa Balpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 101(3):2003;1053-1062.
44. Advani A.S., Pendergast A.M. Bcr-Abl variants: biological and clinical aspects. Leuk. Res. 26(8):2002;713-720.
45. Piwocka K., Zablocki K., Wieckowski M.R., Skierski J., Feiga I., Szopa J., Drela N., Wojtczak L., Sikora E. A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp. Cell Res. 249(2):1999;299-307.
46. Singhal S.S., Awasthi S., Pandya U., Piper J.T., Saini M.K., Cheng J.Z., Awasthi Y.C. The effect of curcumin on glutathione-linked enzymes in K562 human leukemia cells. Toxicol. Lett. 109(1/2):1999;87-95.
47. Tidefelt U., Elmhorn-Rosenborg A., Paul C., Hao X.Y., Mannervik B., Eriksson L.C. Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Res. 52(12):1992;3281-3285.
48. Morales A., Garcia-Ruiz C., Miranda M., Mari M., Colell A., Ardite E., Fernandez-Checa J.C. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of gamma- glutamylcysteine synthetase. J. Biol. Chem. 272(48):1997;30371-30379.
49. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11(9):2001;372-377.
50. Gilot D., Loyer P., Corlu A., Glaise D., Lagadic-Gossmann D., Atfi A., Morel F., Ichijo H., Guguen-Guillouzo C. Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation. J. Biol. Chem. 277(51):2002;49220-49229.